Free Interleukin (IL)-18 levels, and the impact of IL18 and IL18BP genetic variation, in CHD patients and healthy men

Arterioscler Thromb Vasc Biol. 2007 Dec;27(12):2743-9. doi: 10.1161/ATVBAHA.107.149245. Epub 2007 Oct 19.

Abstract

Objective: To investigate free interleukin-18 (fIL-18) levels, and variation within the IL-18 system genes, in heart surgery patients, and healthy men.

Methods and results: fIL-18 was calculated from IL-18 and IL-18 binding protein (BP) levels, in 421 healthy men and 196 post-coronary artery bypass graft (CABG) patients. After surgery, fIL-18 peaked at 6 hours (from 117 to 331 pg/mL) but fell to below presurgery levels at 24 hours (99 pg/mL), because of changes in total IL-18 and IL-18BP. fIL-18 24 hours postsurgery was significantly higher in those who suffered a major complication after surgery (125 versus 80 pg/mL, P<0.01). Baseline total IL-18 was also higher in healthy men who went on to suffer an MI over 17 years of prospective study (276 versus 240 pg/mL, P=0.01). Tagging SNPs for IL18 (n=5) and IL18BP (n=3) were determined, in both studies the IL18 HapIII haplotype (frequency 30%) was associated with 36% lower baseline fIL-18 levels before surgery (P<0.01), and 7% lower in healthy men (P=0.04). The frequency of HapIII was lower in CABG patients than in healthy men (20.7 versus 29.8%, P<0.01).

Conclusions: IL-18 levels, which are determined in part by variation in IL18, play a role in CHD development and postsurgery outcome.

Publication types

  • Multicenter Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Aged
  • Case-Control Studies
  • Coronary Artery Bypass*
  • Coronary Disease / blood*
  • Coronary Disease / genetics
  • Coronary Disease / surgery
  • Europe
  • Follow-Up Studies
  • Gene Frequency
  • Genetic Predisposition to Disease
  • Haplotypes
  • Humans
  • Intercellular Signaling Peptides and Proteins / blood*
  • Intercellular Signaling Peptides and Proteins / genetics
  • Interleukin-18 / blood*
  • Interleukin-18 / genetics
  • Male
  • Middle Aged
  • Myocardial Infarction / blood*
  • Myocardial Infarction / genetics
  • Phenotype
  • Polymorphism, Single Nucleotide*
  • Postoperative Complications / blood*
  • Prospective Studies
  • Risk Factors
  • Time Factors
  • Treatment Outcome

Substances

  • Intercellular Signaling Peptides and Proteins
  • Interleukin-18
  • interleukin-18 binding protein